Cardiology 2013 (Full reference info)

Reference Type: Journal Article
Record Number: 674Author: Bugiardini, R., Manfrini, O., Majstorovic Stakic, M., Cenko, E., Boytsov, S., Merkely, B., Becker, D., Dilic, M., Vasiljevic, Z., Koller, A. and Badimon, L.
Year: 2013
Title: Exploring In-hospital Death from Myocardial Infarction in Eastern Europe; From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology
Journal: Curr Vasc Pharmacol
Date: Apr 22
Short Title: Exploring In-hospital Death from Myocardial Infarction in Eastern Europe; From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology
Alternate Journal: Current vascular pharmacology
ISSN: 1875-6212 (Electronic)
1570-1611 (Linking)
Accession Number: 23607683
Abstract: Introduction: The aim of the current study was to investigate the outcomes of coronary reperfusion therapies and ST-segment elevation myocardial infarction (STEMI) in patients of eastern countries with economies in transition. Methods and Results: We received STEMI registry data from 4 countries: Bosnia and Herzegovina, Hungary, Russian Federation, and Serbia. The overall population consisted of 23,486 consecutive patients admitted to hospitals from January 1st to December 31st 2009. Registry data and statistics from the Organization for Economic Cooperation and Development (OECD) countries for the same period were used for comparison (2009-2010). In-hospital mortality was between 4% and 5% in the Western countries. In comparison mortality data was significantly larger in Serbia (10.8%) and Bosnia and Herzegovina (11.2%), intermediate in Russian Federation (7.2%) and similar in Hungary (5.0%). The rates of primary percutaneous coronary intervention (primary PCI) were very low in Bosnia and Herzegovina (18.3%), low in Russian Federation (20.6%) and Serbia (22%), and high in Hungary (70%). Major risk factors for death appear to be lack of reperfusion therapy, longer time delay from symptoms onset to hospital presentation as well as the higher percentage of patients with clinical presentation in Killip class III/IV. Conclusion: In-hospital STEMI case-fatality rates ranges widely in the former Eastern Bloc countries. Beyond the quality of care provided in hospitals, differences in time delay from symptoms onset to hospital admission may strongly influence STEMI patients’ outcome.
Notes: Bugiardini, Raffaele
Manfrini, Olivia
Majstorovic Stakic, M
Cenko, Edina
Boytsov, Sergei
Merkely, Bela
Becker, David
Dilic, Mirza
Vasiljevic, Zorana
Koller, Akos
Badimon, Lina
ENG
2013/04/24 06:00
Curr Vasc Pharmacol. 2013 Apr 22.
URL: http://www.ncbi.nlm.nih.gov/pubmed/23607683
Author Address: Olivia Manfrini, MD. Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, University of Bologna. Via Massarenti 9 (Padiglione 11), 40138 Bologna, Italy. olivia.manfrini@unibo.it.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155